The FDA has approved revisions to the safety labeling for various selective serotonin and serotonin-norepinephrine reuptake inhibitors; multiple electrolytes injection, type 1; and telbivudine. Medscape Medical News
A meta-analysis shows that nonergot dopamine agonists may significantly reduce symptom severity, but a significant proportion of patients will discontinue use as a result of adverse events. Medscape Medical News
Sandra Fryhofer, MD, reviews ulipristal acetate (ellaŽ), the new contraceptive agent that can prevent pregnancy 5 days after sex. Medscape Internal Medicine
Phase 2b results with oral fumarate, aka BG00012, show that the highest dose was associated with a 69% reduction in new gadolinium-enhancing lesions vs placebo, with a favorable safety profile. Medscape Medical News
Dr. Maurie Markman reports on a Swedish study that presents conclusive findings concerning in vitro fertilization and the risk for ovarian cancer. Medscape Hematology-Oncology
